Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,996

Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides

Schachter, H. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-026 · Cited by 526

Biosynthetic Controls That Determine the Branching and Microheterogeneity of Protein-Bound Oligosaccharides

Schachter, H. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5209-9_2 · Cited by 510

Sequencing of N-Linked Oligosaccharides Directly from Protein Gels: In-Gel Deglycosylation Followed by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Normal-Phase High-Performance Liquid Chromatography

Küster, B., Wheeler, S. F., Hunter, A. P., Dwek, R. A., & Harvey, D. J. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2199 · Cited by 358

Effect of glycosylation on antibody function: implications for genetic engineering

Wright, A. M., & Morrison, S. L. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 317

Quantitative aspects of the matrix‐assisted laser desorption mass spectrometry of complex oligosaccharides

Harvey, D. J. (1993) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1290070712 · Cited by 265

In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production

Bibila, T. A., & Robinson, D. K. (1995) · Biotechnology Progress · doi:10.1021/bp00031a001 · Cited by 251

Overlapping distribution of two glycosyltransferases in the Golgi apparatus of HeLa cells.

Nilsson, T., Pypaert, M., Hoe, M. H., Slusarewicz, P., Berger, E. G., & Warren, W. G. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.1.5 · Cited by 222

Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc γ receptor I and influence the synthesis of its oligosaccharide chains

Lund, J., Takahashi, N., Pound, J. D., Goodall, M. D., & Jefferis, R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4963 · Cited by 216

Improving expression of recombinant human IGF‐1 using IGF‐1R knockout CHO cell lines

Romand, S., Jostock, T., Fornaro, M., Schmidt, J., Ritter, A., Wilms, B., & Laux, H. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25877 · Cited by 15

The Effect of Cell Culture Parameters on Protein Glycosylation

Restelli, V., & Butler, M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47525-1_2 · Cited by 15

Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans

Tsukimura, W., Kurogochi, M., Mori, M., Osumi, K., Matsuda, A., Takegawa, K., Furukawa, K., & Shirai, T. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1394813 · Cited by 15

Systems Glycobiology: Immunoglobulin G Glycans as Biomarkers and Functional Effectors in Aging and Diseases

Kavur, M. M., Lauc, G., & Pezer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00086-9 · Cited by 15

Monoclonal Antibodies: From Structure to Therapeutic Application

Davis, J. D., Deng, R., Boswell, C. A., Zhang, Y., Li, J., Fielder, P. J., Joshi, A., & Kenkare-Mitra, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0_7 · Cited by 14

Fast Characterization of Fc-Containing Proteins by Middle-Down Mass Spectrometry Following IdeS Digestion

Liu, T., Guo, H., Zhu, L., Zheng, Y., Xu, J., Guo, Q., Zhang, D., Qian, W., Dai, J., Guo, Y., et al. (2016) · Chromatographia · doi:10.1007/s10337-016-3173-2 · Cited by 14

Genetic modification of a chicken expression system for the galactosylation of therapeutic proteins produced in egg white

Mizutani, A., 綱島, 裕., Nishijima, K.-I., Sasamoto, T., Yamada, Y., Kojima, Y., Motono, M., Kojima, J., Inayoshi, Y., Miyake, K., et al. (2011) · Transgenic Research · doi:10.1007/s11248-011-9511-0 · Cited by 14

Novel macrolide‐adjustable bidirectional expression modules for coordinated expression of two different transgenes in mice

Fux, C., Weber, W., Baba, M. D., Heinzen, C., Aubel, D., & Fussenegger, M. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.443 · Cited by 14

Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations

Parchment, R. E., Voth, A. R., Doroshow, J. H., & Berzofsky, J. A. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.06.008 · Cited by 13

Glycosylation States on Intact Proteins Determined by NMR Spectroscopy

Hargett, A. A., Marcella, A. M., Yu, H., Li, C., Orwenyo, J., Battistel, M. D., Wang, L., & Freedberg, D. I. (2021) · Molecules · doi:10.3390/molecules26144308 · Cited by 13

ADCC enhancement: A conundrum or a boon to mAb therapy?

Narvekar, A., Pardeshi, A., Jain, R. D., & Dandekar, P. P. (2022) · Biologicals · doi:10.1016/j.biologicals.2022.08.006 · Cited by 14

Evolving therapeutic proteins to precisely kill cancer cells

Zaman, R., Islam, R. A., & Chowdhury, E. H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.066 · Cited by 13

Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy

Hart, F., Danielczyk, A., & Goletz, S. (2017) · Bioengineering · doi:10.3390/bioengineering4020042 · Cited by 13

Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against Cancer

Kang, T. H., & Jung, S. T. (2020) · Biomolecules · doi:10.3390/biom10030382 · Cited by 14

Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity

Calow, J., Behrens, A., Mader, S., Bockau, U., Struwe, W. B., Harvey, D. J., Cormann, K. U., Nowaczyk, M. M., Loser, K., Schinor, D., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1228504 · Cited by 13

IgG glycosylation in autoimmune diseases

Kozłowska, K., Rydlewska, M., Ząbczyńska, M., & Pocheć, E. (2018) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0012.7351 · Cited by 13

Fusion Proteins: Applications and Challenges

Schmidt, S. R. (2013) · doi:10.1002/9781118354599.ch1 · Cited by 13

Glycosylation of Therapeutic IgGs

Mimura, Y., Jefferis, R., Mimura‐Kimura, Y., Abrahams, J. L., & Rudd, P. M. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch3 · Cited by 13

A 2-year calorie restriction intervention may reduce glycomic biological age biomarkers – a pilot study

Pribić, T., Das, J., Đerek, L., Belsky, D. W., Orenduff, M. C., Huffman, K. M., Kraus, W. E., Deriš, H., Šimunović, J., Štambuk, T., et al. (2025) · npj Aging · doi:10.1038/s41514-025-00254-9 · Cited by 13

Sweet Rules: Linking Glycosylation to Antibody Function

Nimmerjahn, F., & Werner, A. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_12 · Cited by 12

DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity

Sustmann, C., Dickopf, S., Regula, J. T., Kettenberger, H., Mølhøj, M., Gassner, C., Weininger, D., Fenn, S., Manigold, T., Kling, L., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1661736 · Cited by 12

Analytical Characterization of Monoclonal Antibodies: Linking Structure to Function

Harris, R. J., Chin, E. T., Macchi, F. D., Keck, R. G., Shyong, B., Ling, V. T., Cordoba, A. J., Marian, M., Sinclair, D., Battersby, J. E., et al. (2009) · Springer eBooks · doi:10.1007/978-0-387-76643-0_12 · Cited by 13

Combination of SDS‐PAGE and intact mass analysis for rapid determination of heterogeneities in monoclonal antibody therapeutics

Yamada, H., Matsumura, C., Yamada, K., Teshima, K., Hiroshima, T., Kinoshita, M., Suzuki, S., & Kakehi, K. (2017) · Electrophoresis · doi:10.1002/elps.201700014 · Cited by 12

Reprogramming immune proteins as therapeutics using molecular engineering

Kureshi, R., Bahri, M., & Spangler, J. B. (2017) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2017.12.003 · Cited by 12

Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin

Murer, P., Kiefer, J. D., Plüss, L., Matasci, M., Blümich, S., Stringhini, M., & Neri, D. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.028 · Cited by 12

A Single Excitation‐Duplexed Imaging Strategy for Profiling Cell Surface Protein‐Specific Glycoforms

Wu, N., Bao, L., Ding, L., & Ju, H. (2016) · Angewandte Chemie · doi:10.1002/ange.201601233 · Cited by 12

Humanization of recombinant glycoproteins expressed in insect cells

Tomiya, N. (2009) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.21.71 · Cited by 12

Tailoring immunoglobulin Fc for highly potent and serum-stable therapeutic antibodies

Jung, S. T. (2013) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-012-0711-0 · Cited by 12

Role of monoclonal antibodies in tumor-specific immunity

Nicodemus, C. F., Smith, L. M., & Schultes, B. C. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.3.331 · Cited by 12

The Future of Antibody Therapy

Buelow, R., & van Schooten, W. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2007_040 · Cited by 12

Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection

Zou, G., Košíková, M., Kim, S.-R., Kotian, S., Wu, W. W., Shen, R., Powers, D. N., Agarabi, C. D., Xie, H., & Ju, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005294 · Cited by 12

Potelligent Antibodies as Next Generation Therapeutic Antibodies

Shitara, K. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.3 · Cited by 12

Humanized Glycosylation: Production of Biopharmaceuticals in a Moss Bioreactor

Gorr, G., & Wagner, S. (2005) · Wiley eBooks · doi:10.1002/9783527620982.ch37 · Cited by 12

Bisecting N-Acetylglucosamine of the N-Glycan of Immunoglobulin G Does Not Affect Binding to Fc Gamma Receptors

Bosman, G. P., Stoof, I. D., Bastiaansen, H. P., van Ufford, L. Q., Dobruchowska, J. M., Langenbach, J.-W. H., Boruah, B. M., Moremen, K. W., Bentlage, A. E. H., Lissenberg‐Thunnissen, S. N., et al. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.4c00807 · Cited by 10

Obinutuzumab For The Treatment Of Indolent Lymphoma

Edelmann, J., & Gribben, J. G. (2016) · Future Oncology · doi:10.2217/fon-2016-0084 · Cited by 11

Glycoengineering and glycosite-specific labeling of serum IgGs from various species

Guo, W., Tang, F., Qin, K., Zhou, M., Le, Z., & Huang, W. (2017) · Carbohydrate Research · doi:10.1016/j.carres.2017.05.001 · Cited by 11

Engineering antibody-based molecules for HIV treatment and cure

Tuyishime, M., & Ferrari, G. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000640 · Cited by 11

7th Annual European Antibody Congress 2011

Lugovskoy, A. A., Reichert, J. M., & Beck, A. (2012) · mAbs · doi:10.4161/mabs.4.2.19426 · Cited by 11

Enhanced efficacy of glycoengineered rice cell‐produced trastuzumab

Shin, J., Oh, S., Jang, M., Lee, S., Min, C., Eu, Y., Begum, H., Kim, J., Lee, G. R., Oh, H. B., et al. (2024) · Plant Biotechnology Journal · doi:10.1111/pbi.14429 · Cited by 10

Fucose-Targeted Glycoengineering of Pharmaceutical Cell Lines

Ogorek, C., Jordan, I., Sandig, V., & von Horsten, H. H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-974-7_29 · Cited by 10

Quantification of protein posttranslational modifications using stable isotope and mass spectrometry

Jiang, X. G., Apostoł, I., Luo, Q., Lewis, J. K., Keener, R. N., Luo, S., Jerums, M., Zhang, X., Wypych, J., & Huang, G. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.12.004 · Cited by 10

Application of Quality by Design Paradigm to the Manufacture of Protein Therapeutics

del Val, I. J., Philip, M., Exley, K., Sou, S. N., Kyriakopoulos, S., Polizzi, K. M., & Kontoravdi, C. (2012) · InTech eBooks · doi:10.5772/50261 · Cited by 12

Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro

Yi, C., Ruan, C., Wang, H., Xu, X., Zhao, Y., Fang, M., Ji, J., Gu, X., & Gao, C. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.77 · Cited by 10

Enrichment of high affinity subclasses and glycoforms from serum‐derived IgG using FcγRs as affinity ligands

Boesch, A. W., Kappel, J. H., Mahan, A. E., Chu, T. H., Crowley, A. R., Osei‐Owusu, N. Y., Alter, G., & Ackerman, M. E. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26545 · Cited by 10

Enhancing FcγR-mediated antibody effector function during persistent viral infection

Wieland, A., Kamphorst, A. O., Valanparambil, R. M., Han, J.-H., Xu, X., Choudhury, B., & Ahmed, R. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao3125 · Cited by 10

Fully galactosyl-fucosyl-bisected IgG1 reduces anti-HBV efficacy and liver histological improvement

Ho, C.-H., Chen, S., Tsai, H., Wu, I., & Chang, T. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2018.12.021 · Cited by 10

Methods to measure the binding of therapeutic monoclonal antibodies to the human Fc receptor FcγRIII (CD16) using real time kinetic analysis and flow cytometry

Harrison, A., Liu, Z., Makweche, S., Maskell, K. F., Qi, H., & Hale, G. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.01.029 · Cited by 10

Synthetic Glycopeptides Allow for the Quantitation of Scarce Nonfucosylated IgG Fc N-Glycans of Therapeutic Antibody

Hammura, K., Ishikawa, A., V., R. K. H., Miyoshi, R., Yokoi, Y., Tanaka, M., Hinou, H., & Nishimura, S. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00127 · Cited by 10

Therapeutic Antibodies

Satoh, M., Shitara, K., & Hanai, N. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00124-0 · Cited by 10

Quorum-Sensing-Based Toolbox for Regulatable Transgene and siRNA Expression in Mammalian Cells

Weber, W., Malphettes, L., Rinderknecht, M., Schoenmakers, R. G., Spielmann, M., Keller, B., van de Wetering, P., Weber, C. C., & Fussenegger, M. (2005) · Biotechnology Progress · doi:10.1021/bp0498995 · Cited by 10

Twelve Years of Genome-Wide Association Studies of Human Protein N-Glycosylation

Timoshchuk, A. N., Sharapov, S., & Aulchenko, Y. S. (2023) · Engineering · doi:10.1016/j.eng.2023.03.013 · Cited by 9

Introduction of Carbonyl Groups into Antibodies

Gulyak, E. L., Alferova, V. A., Аркадьевич, К. В., & Sapozhnikova, K. A. (2023) · Molecules · doi:10.3390/molecules28237890 · Cited by 9

Application of a new human cell line, F2N78, in the transient and stable production of recombinant therapeutics

Lee, H., Chang, M., Kim, J., Hong, H.-J., Maeng, K. E., Koo, J., Chang, S.-J., & Cho, M. (2013) · Biotechnology Progress · doi:10.1002/btpr.1685 · Cited by 9

Targeted Shifting of Protein Glycosylation Profiles in Mammalian Cell Culture through Media Supplementation of Cobalt

Hossler, P., & Racicot, C. (2015) · Journal of Glycobiology · doi:10.4172/2168-958x.1000108 · Cited by 9

Monoclonal antibody pharmacogenomics in cancer treatment

Yagishita, S., & Hamada, A. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.026 · Cited by 9

In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris

Gomathinayagam, S., Laface, D., Houston-Cummings, N. R., Mangadu, R., Moore, R., Shandil, I., Sharkey, N., Li, H., Stadheim, T. A., & Zha, D. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.05.005 · Cited by 9

TNF receptor II fusion protein with tandemly repeated Fc domains

Nagashima, H., Kaneko, K., Yamanoi, A., Motoi, S., Konakahara, S., Kohroki, J., & Masuho, Y. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvq149 · Cited by 9

Recombinant antibodies in the immunotherapy of neuroblastoma: perspectives of new developments

Bestagno, M., Occhino, M., Corrias, M. V., Burrone, Ó. R., & Pistoia, V. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00109-5 · Cited by 9

Cell Line Development

Castan, A., Schulz, P., Wenger, T., & Fischer, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100623-8.00007-4 · Cited by 9

Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions

Dall’Olio, F., & Malagolini, N. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_10 · Cited by 9

Building a Cell Culture Process with Stable Foundations: Searching for Certainty in an Uncertain World

O’Callaghan, P. M., & Racher, A. J. (2014) · Cell engineering · doi:10.1007/978-3-319-10320-4_12 · Cited by 10

Large Scale Suspension Culture of Mammalian Cells

Alldread, R. M., Birch, J. R., Metcalfe, H. K., Farid, S. S., Racher, A. J., Young, R. J., & Khan, M. (2014) · Wiley eBooks · doi:10.1002/9783527683321.ch12 · Cited by 9

Anti-Idiotypic Antibody as the Surrogate Antigen for Cloning scFv and its Fusion Proteins

Cheung, N. V., Guo, H.-F., Modak, S. I., & Cheung, I. Y. (2002) · Hybridoma and Hybridomics · doi:10.1089/153685902321043963 · Cited by 9

Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines

Puagsopa, J., Tongviseskul, N., Jaroentomeechai, T., & Meksiriporn, B. (2025) · Vaccines · doi:10.3390/vaccines13030285 · Cited by 8

Chemical and Chemoenzymatic Synthesis of Peptide and Protein Therapeutics Conjugated with Human N‐Glycans

Ochiai, H., Elouali, S., Yamamoto, T., Asai, H., Noguchi, M., & Nishiuchi, Y. (2024) · ChemMedChem · doi:10.1002/cmdc.202300692 · Cited by 9

Recent Advances in Glycosylation Modifications in the Context of Therapeutic Glycoproteins

Zhong, X., & Somers, W. (2012) · InTech eBooks · doi:10.5772/29708 · Cited by 8

Dissecting the Antibody Constant Region Protective Immune Parameters in HIV Infection

Chung, A. W., & Alter, G. (2014) · Future Virology · doi:10.2217/fvl.14.19 · Cited by 9

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein

Bordoloi, D., Xu, Z., Ho, M., Purwar, M., Bhojnagarwala, P. S., Cassel, J. A., Giron, L. B., Walker, S. N., Kulkarni, A. J., Tello‐Ruiz, E., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00058 · Cited by 8

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck – the RESGEX study

Klinghammer, K. F., Fayette, J., Kawecki, A., Dietz, A., Schafhausen, P., Folprecht, G., Rottey, S., Debourdeau, P., Lavernia, J., Jacobs, A., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100242 · Cited by 8

Glycosylation of Plant-Produced Immunoglobulins

Göritzer, K., & Strasser, R. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_16 · Cited by 8

Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects

Nawab, D. H. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1985891 · Cited by 9

A Chromatographic Approach for Elevating the Antibody-Dependent Cellular Cytotoxicity of Antibody Composites

Tojo, S., Okazaki, A., Wakitani, M., Shinkawa, T., Uchida, K., & Suzawa, T. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1604 · Cited by 8

B Cell-Based Seamless Engineering of Antibody Fc Domains

Hashimoto, K., Kurosawa, K., Murayama, A., Seo, H., & Ohta, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167232 · Cited by 8

Impact of Fc Glycosylation on Monoclonal Antibody Effector Functions and Degradation by Proteases

Raju, T. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-76643-0_15 · Cited by 9

Engineering the Antibody Fc Region for Optimal Effector Function

Lazar, G. A., & Desjarlais, J. R. (2009) · doi:10.1002/9780470485408.ch15 · Cited by 8

Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography

Fox, J. M., Roy, V., Gunn, B. M., Bolton, G., Fremont, D. H., Alter, G., Diamond, M., & Boesch, A. W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1153108 · Cited by 7

Antibody interfaces revealed through structural mining

Yin, Y., Romei, M. G., Sankar, K., Pal, L. R., Hoi, K. H., Yang, Y., Leonard, B. C., Boenig, G. D. L., Kumar, N., Matsumoto, M., et al. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.048 · Cited by 7

Glycosylation in Cell Culture

Spearman, M. A., & Butler, M. (2014) · Cell engineering · doi:10.1007/978-3-319-10320-4_9 · Cited by 8

Anticorps monoclonaux : tours et détours technologiques pour de nouveaux espoirs thérapeutiques

Bourel, D., & Teillaud, J. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2006.02.006 · Cited by 7

Early Characterization of Biosimilar Therapeutics

Gelzleichter, T. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394810-6.00007-1 · Cited by 7

Metabolic engineering of CHO cells to prepare glycoproteins

Wang, Q., & Betenbaugh, M. J. (2018) · Emerging Topics in Life Sciences · doi:10.1042/etls20180056 · Cited by 7

Application of Genetic Engineering in Biotherapeutics Development

Schweickert, P. G., & Cheng, Z. (2019) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-019-09411-6 · Cited by 8

In Vitro Antitumoral Activity of Baculovirus-expressed Chimeric Recombinant Anti-CD4 Antibody 13B8.2 on T-cell Lymphomas

Troadec, S., Chentouf, M., Cérutti, M., Nguyen, B., Olive, D., Bès, C., & Chardès, T. (2007) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211331.61019.26 · Cited by 7

Development and validation of online SPE purification coupled to HILIC-fluorescence-MS analysis for the characterization of N-glycans

Helali, Y., Bourez, A., Marchant, A., Heyden, Y. V., Antwerpen, P. V., & Delporte, C. (2023) · Talanta · doi:10.1016/j.talanta.2023.125541 · Cited by 7

Glycoproteomics in Health and Disease

Struwe, W. B., Cosgrave, E. F. J., Byrne, J. C., Saldova, R., & Rudd, P. M. (2010) · Springer eBooks · doi:10.1007/978-90-481-9355-4_1 · Cited by 6

Capillary Electrophoresis of Carbohydrates

Kakehi, K., & Suzuki, S. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00033-7 · Cited by 6

In Silico Analysis of Therapeutic Antibody Aggregation and the Influence of Glycosylation

Jeon, H., Hayes, J. M., & Mok, K. H. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1685-7_8 · Cited by 6

Determination of Antibody Glycosylation by Mass Spectrometry

Jäger, C., Ferrara, C., Umaña, P., Zeck, A., Regula, J. T., & Koll, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-931-0_13 · Cited by 6

Recombinant IgA Antibodies

Yoo, E. M., Chintalacharuvu, K. R., & Morrison, S. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-72232-0_15 · Cited by 6

Application of a Reversible Immortalization System for the Generation of Proliferation-Controlled Cell Lines

May, T., Lindenmaier, W., Wirth, D., & Mueller, P. P. (2004) · Cytotechnology · doi:10.1007/s10616-005-2834-z · Cited by 6

Qu’est-ce qu’une biothérapie ? L’exemple des anticorps monoclonaux

Teillaud, J. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2008.12.025 · Cited by 8

Glycosylation of Recombinant Proteins in Plan

Gorr, G., & Altmann, F. (2006) · Wiley eBooks · doi:10.1002/9783527619771.ch15 · Cited by 6

Engineering O -glycosylation in modified N -linked oligosaccharide (Man 12 GlcNAc 2 ∼Man 16 GlcNAc 2 ) Pichia pastoris strains

Li, S., Sun, P., Gong, X., Chang, S., Li, E., Xu, Y., Wu, J., & Liu, B. (2019) · RSC Advances · doi:10.1039/c8ra08121b · Cited by 5

Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform

Nguyen, N. T. B., Leung, H. W., Pang, K. T., Tay, S. J., Walsh, I., Choo, A. B. H., & Yang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-42925-1 · Cited by 5

Combinatory glycoengineering of monoclonal antibodies and its application in cancer therapy: a narrative review

Wang, S., Tian, H., Tian, P., Xing, Y., & Zeng, Y. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1371 · Cited by 6

Therapeutic Antibodies and Immunologic Conjugates

Cheung, N. V. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00032-1 · Cited by 5

Present and future of therapeutic recombinant antibodies

Langjahr, P., & Sotelo, P. H. (2016) · Memorias del Instituto de Investigaciones en Ciencias de la Salud · doi:10.18004/mem.iics/1812-9528/2016.014(02)110-121 · Cited by 5

Low amounts of bisecting glycans characterize cerebrospinal fluid-borne IgG

Knopf, J., Magorivska, I., Maler, J. M., Spitzer, P., Bilyy, R. O., Biermann, M. H. C., Hychka, К. М., Bondt, A., Wuhrer, M., Toes, R. E. M., et al. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.010 · Cited by 5

Engineering Antibodies for Cancer Therapy

Goldsmith, L. E., & Robinson, M. K. (2011) · Cell engineering · doi:10.1007/978-94-007-1257-7_10 · Cited by 5

Application of Antibody Engineering in the Development of Next Generation Antibody-Based Therapeutics

Brezski, R. J., & Almagro, J. C. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5955-3_4 · Cited by 5

Influence of Variable N-Glycosylation on the Cytolytic Potential of Chimeric CD19 Antibodies

Barbin, K., Stieglmaier, J., Saul, D., Stieglmaier, K., Stockmeyer, B., Pfeiffer, M. M., Lang, P., & Fey, G. H. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000175684.28615.7b · Cited by 28

Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII

Davies, J., Jiang, L., Pan, L., LaBarre, M. J., Anderson, D., & Reff, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1119 · Cited by 327

Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co‐expression of heterologous β1, 4‐N‐acetylglucosaminyltransferase III and Golgi α‐mannosidase II

Ferrara, C., Brünker, P., Suter, T., Moser, S., Püntener, U., & Umaña, P. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20777 · Cited by 305

Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering

Schuster, M., Umaña, P., Ferrara, C., Brünker, P., Gerdes, C. A., Waxenecker, G., Wiederkum, S., Schwager, C., Loibner, H., Himmler, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4212 · Cited by 91

Engineering of protein glycosylation in Chinese hamster ovary cells

Umaña, P. (2005) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/6ceh-kt92 · Cited by 1